EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Medical University of Vienna, Zuyderland Medisch Centrum, Amsterdam University Medical Centers, University Medical Center Utrecht, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Hôpital Cochin, University of Glasgow, Leiden University Medical Center, Universidade Nova de Lisboa, Amsterdam UMC Location Vrije Universiteit Amsterdam, Cal Humanities, European League Against Rheumatism, University Hospital Carl Gustav Carus, Karolinska University Hospital, Hospital Universitario La Paz, Vrije Universiteit Amsterdam, Sint Maartenskliniek, University of Manchester, Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, University of Milan, University of Pavia, Istituti di Ricovero e Cura a Carattere Scientifico, Universidad de Morelia, KU Leuven, University of Genoa, University Hospital Southampton NHS Foundation Trust, NIHR Southampton Biomedical Research Centre, Maastricht University, University of Leeds, Leeds Teaching Hospitals NHS Trust, NIHR Leeds Musculoskeletal Biomedical Research Unit, University Hospital of Geneva, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, Centre National de la Recherche Scientifique, Immunologie, Immunopathologie et Chimie Thérapeutique, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, University of Copenhagen, Rigshospitalet, Peking University, Peking University People's Hospital, Université Paris-Sud, Université Paris-Saclay, Justus-Liebig-Universität Gießen, Hospitais da Universidade de Coimbra, Semmelweis University, Western University, Kantonsspital St. Gallen, Université Toulouse III - Paul Sabatier, University of Alabama at Birmingham, German Rheumatism Research Centre, Keio University Hospital, University of Twente